Background: Currently an echocardiographic threshold for the tricuspid regurgitation gradient (TRG) of > 31 mmHg is recommended for screening for pulmonary hypertension (PH). Invasively diagnosed PH was recently redefined as mean pulmonary arterial pressure (mPAP) > 20 mmHg instead of ≥ 25 mmHg. We investigated the ability of TRG to screen for the new PH-definition.
Methods: Retrospective assessment of echocardiography and right heart catheterisation data from 1572 patients entering the Giessen PH-Registry during 2008-2018. Accuracy of different TRG thresholds and other echocardiographic parameters was evaluated using receiver operating characteristic curves.
Findings: 1264 patients fulfilled the new PH-definition. Positive (PPV) and negative predictive values and accuracy of TRG > 46 mmHg were 95%, 39%, and 73%, respectively, for the new PH-definition. Lowering the TRG cut-off to 31 mmHg and below worsened PPV to ≤ 89%. The PPV of TRG for pre-capillary PH (mPAP > 20 mmHg and pulmonary vascular resistance ≥ 3 Wood Units) was ≤ 85%. In patients with TRG ≤ 46 mmHg, tricuspid annular plane systolic excursion/TRG and TRG/right ventricular outflow tract acceleration time were superior to TRG in screening for newly defined pre-capillary PH.
Interpretation: In patients with suspected PH referred to a tertiary care centre, the PPV of TRG to meet the new PH-definition depended strongly on the TRG cut-off used. Our data do not support lowering the TRG cut-off. Combining TRG with other echocardiographic parameters might improve the validity of echocardiographic screening for PH.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8102717 | PMC |
| http://dx.doi.org/10.1016/j.eclinm.2021.100822 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
FoxP3 Regulatory T-Cell Quantities in Nodal T-Follicular Helper Cell Lymphomas and Peripheral T-Cell Lymphomas Not Otherwise Specified and Their Impact on Overall Survival.
Cancers (Basel)
November 2024
Department of Pathology, Institute of Oncology Ljubljana, Zaloška Cesta 2, 1000 Ljubljana, Slovenia.
Background/objectives: The tumour microenvironment (TME) plays an important role in the development and progression of cancer and it differs among lymphomas, both with respect to the composition and quantity of specific tumour-infiltrating immune cells (TICs), such as FoxP3 regulatory T cells (Tregs). The role of FoxP3 Tregs in the TME of peripheral T-cell lymphomas (PTCLs) is complex, and their impact on overall survival (OS) remains unclear. Consequently, we aim to evaluate and compare the FoxP3 cell quantity in nodal PTCLs and reactive lymph nodes (LNs), with a focus on investigating their impact on OS.
View Article and Find Full Text PDFCombined systemic inflammatory immune index and prognostic nutrition index as chemosensitivity and prognostic markers for locally advanced gastric cancer receiving neoadjuvant chemotherapy: a retrospective study.
BMC Cancer
August 2024
Research Center and Tumor Research Institute, The Fourth Hospital of Hebei Medical University, Shijiazhuang, 050011, Hebei, China.
Article Synopsis
- The study investigates the combined impact of the Prognosis Nutritional Index (PNI) and Systemic Inflammatory Immunological Index (SII) on predicting tumor response and prognosis in patients with locally advanced gastric cancer (LAGC) after chemotherapy.
- A retrospective analysis of 181 LAGC patients was conducted, categorizing them into tumor regression grade (TRG) 3 and non-TRG3 groups, and assessing their SII and PNI values.
- Results showed that higher SII-PNI scores were linked to better tumor responses and poorer overall and disease-free survival, indicating the SII-PNI score could be a useful predictor in clinical settings.
Restaging of rectal cancer with hybrid positron emission tomography magnetic resonance imaging after preoperative chemoradiotherapy.
Ann Acad Med Singap
June 2023
Department of Radiology, National University Hospital, Singapore.
Article Synopsis
- - The study investigates how effectively PET/MRI can predict treatment response in localized rectal cancer patients undergoing preoperative chemoradiotherapy (CRT), focusing on sensitivity and specificity of imaging parameters.
- - Out of 31 recruited patients with rectal adenocarcinoma, 20 completed the study; results showed that 20% of patients were good responders to treatment, while 80% had a poor response based on histopathological assessments.
- - Key imaging metrics like percent maximum thickness reduction and percent apparent diffusion coefficient (ADC) change demonstrated promising predictive values, suggesting their potential use in identifying good responders, highlighting the need for larger studies to validate these findings.
Abemaciclib for the Treatment of HR+HER2- Metastatic Breast Cancer: An Institutional Experience.
Cancers (Basel)
May 2024
Department of Medical Oncology, Institute of Oncology Ljubljana, Zaloška 2, 1000 Ljubljana, Slovenia.
(1) Background: Abemaciclib combined with endocrine therapy is a standard first- or later-line of treatment for HR+/HER2- metastatic breast cancer (MBC). The aim of this retrospective cohort study was to describe the outcomes of patients treated in a real-world setting, with particular focus on elderly patients. (2) Patients and methods: Patients treated with abemaciclib between November 2019 and February 2022 were included in the study.
View Article and Find Full Text PDFEvaluation of the prognostic impact of pathologic tumor regression grade on patients with colorectal cancer after preoperative chemoradiotherapy.
J Surg Oncol
June 2024
Diagnostic Pathology Center, Southern Tohoku General Hospital, Koriyama, Fukushima, Japan.
Background: The prognostic value of the pathological response to preoperative chemoradiotherapy (CRT) in rectal cancer (RC) remains unknown.
Objectives: We aimed to assess the predictive value of the response to CRT that was derived from an evaluation of the histological findings (whole-section vs. representative-section sampling) and attempted to determine an objective cut-off value for the tumor regression grade (TRG).
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!